BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8778315)

  • 1. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.
    Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT
    J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
    Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
    Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
    Cardillo MR; Yap EP
    Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.
    Sanjuán X; Fernández PL; Miquel R; Muñoz J; Castronovo V; Ménard S; Palacín A; Cardesa A; Campo E
    J Pathol; 1996 Aug; 179(4):376-80. PubMed ID: 8869283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
    Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
    J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
    Cardillo MR; Yap E
    J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
    Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY
    Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis.
    Jiang PS; Yung BY
    Biochem Biophys Res Commun; 1999 Apr; 257(3):865-70. PubMed ID: 10208875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.
    Bocker T; Bittinger A; Wieland W; Buettner R; Fauser G; Hofstaedter F; Rüschoff J
    Mod Pathol; 1995 Apr; 8(3):226-31. PubMed ID: 7542384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
    Hsu CY; Yung BY
    Oncogene; 1998 Feb; 16(7):915-23. PubMed ID: 9484783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
    Liu WH; Yung BY
    Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas.
    Gassler N; Herr I; Schneider A; Penzel R; Langbein L; Schirmacher P; Kopitz J
    J Pathol; 2005 Nov; 207(3):295-300. PubMed ID: 16110457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23.
    Chou YH; Yung BY
    Biochem Biophys Res Commun; 1995 Dec; 217(1):313-25. PubMed ID: 8526928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
    El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
    J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic role of nucleophosmin/B23.
    Yung BY
    Chang Gung Med J; 2007; 30(4):285-93. PubMed ID: 17939258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for post-transcriptional down-regulation of the apoptosis-related gene bcl-2 in human colorectal cancer.
    Berney CR; Downing SR; Yang JL; Russell PJ; Crowe PJ
    J Pathol; 2000 May; 191(1):15-20. PubMed ID: 10767713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
    Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
    J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.